Literature DB >> 9669242

Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain.

C A Polanczyk1, T H Lee, E F Cook, R Walls, D Wybenga, G Printy-Klein, L Ludwig, G Guldbrandsen, P A Johnson.   

Abstract

OBJECTIVES: We sought to evaluate the diagnostic and prognostic value of cardiac troponin I (cTnI) in emergency department (ED) patients with chest pain.
BACKGROUND: Although cTnI has been shown to correlate with an increased risk for complications in patients with unstable angina, the prognostic significance of this assay in the heterogeneous population of patients who present to the ED with chest pain is unclear.
METHODS: cTnI and creatine kinase-MB fraction (CK-MB) mass concentration were collected serially during the first 48 h from onset of symptoms in 1,047 patients > or =30 years old admitted for acute chest pain. Sensitivity, specificity and receiver operating characteristic curves were calculated for cTnI and CK-MB collected in the first 24 h.
RESULTS: The sensitivity, specificity and positive predictive value of cTnI for major cardiac events were 47%, 80% and 19%, respectively. Among patients were who ruled out for myocardial infarction, cTnI was elevated in 26% who had major cardiac complications compared with 5% for CK-MB; the positive predictive value for an abnormal cTnI result was 8%. Elevated cTnI in the presence of ischemia on the electrocardiogram was associated with an adjusted odds ratio of 1.8 (95% confidence interval 1.1 to 2.9) for major cardiac events within 72 h. Among patients without a myocardial infarction or unstable angina, cTnI was not an independent correlate of complications.
CONCLUSIONS: In patients presenting to the ED with acute chest pain, cTnI was an independent predictor of major cardiac events, However, the positive predictive value of an abnormal assay result was not high in this heterogeneous cohort.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9669242     DOI: 10.1016/s0735-1097(98)00176-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  19 in total

1.  The NVVC working group guidelines for the management of patients with non-ST-elevation acute coronary syndromes.

Authors:  R J de Winter
Journal:  Neth Heart J       Date:  2002-02       Impact factor: 2.380

2.  Do induced tachycardias within the scope of electrophysiological studies lead to elevated plasma troponin I levels?

Authors:  D Bandorski; H Bogossian; B Lemke; R Höltgen; M Wieczorek; M Brück
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2011-12

3.  Utility of cardiac troponin I, creatine kinase-MB(mass), myosin light chain 1, and myoglobin in the early in-hospital triage of "high risk" patients with chest pain.

Authors:  G S Hillis; N Zhao; P Taggart; W C Dalsey; A Mangione
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

4.  Risk stratification of patients with acute chest pain and normal troponin concentrations.

Authors:  J Sanchis; V Bodí; A Llácer; J Núñez; L Consuegra; M J Bosch; V Bertomeu; V Ruiz; F J Chorro
Journal:  Heart       Date:  2005-08       Impact factor: 5.994

5.  Unusual towering elevation of troponin I after ST-elevation myocardial infarction and intensive monitoring with echocardiography post-percutaneous coronary intervention: a case report.

Authors:  Fahad Javed; Shahzeb A Khan; Emad F Aziz; Taimur Abbasi; Ramya Suryadevara; Eyal Herzog
Journal:  J Med Case Rep       Date:  2010-05-18

Review 6.  Critical pathways for patients with acute chest pain at low risk.

Authors:  Kirsten E Fleischmann; Lee Goldman; Paula A Johnson; Richard A Krasuski; J Stephen Bohan; L Howard Hartley; Thomas H Lee
Journal:  J Thromb Thrombolysis       Date:  2002-04       Impact factor: 2.300

7.  Cardiac troponin I as prognostic marker in heart failure patients discharged from emergency department.

Authors:  Nicola Parenti; Silvia Bartolacci; Flavia Carle; Fanciulli Angelo
Journal:  Intern Emerg Med       Date:  2008-02-14       Impact factor: 3.397

8.  Partial and delayed release of troponin-I compared with the release of lactate dehydrogenase from necrotic cardiomyocytes.

Authors:  Lijuan Li; Marleen Hessel; Lizet van der Valk; Minka Bax; Irma van der Linden; Arnoud van der Laarse
Journal:  Pflugers Arch       Date:  2004-02-06       Impact factor: 3.657

Review 9.  Predicting cancer therapy-induced cardiotoxicity: the role of troponins and other markers.

Authors:  Joseph A Sparano; David L Brown; Antonio C Wolff
Journal:  Drug Saf       Date:  2002       Impact factor: 5.228

10.  The role of cardiac troponin I as a prognosticator in critically ill medical patients: a prospective observational cohort study.

Authors:  Daniel A King; Shlomi Codish; Victor Novack; Leonid Barski; Yaniv Almog
Journal:  Crit Care       Date:  2005-05-31       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.